131
Li, Xuechun, Bijlsma, Maarten J, Bos, Jens H J, Schuiling-Veninga, Catharina C M, Hak, Eelko
Veröffentlicht in: Li , X , Bijlsma , M J , Bos , J H J , Schuiling-Veninga , C C M & Hak , E 2023 , ' Long-term comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events : A population-based retrospective inception cohort study in the Netherlands ' , BMJ Open , vol. 13 , no. 8 , e068721 . https://doi.org/10.1136/bmjopen-2022-068721;
2023
Veröffentlicht in: Li , X , Bijlsma , M J , Bos , J H J , Schuiling-Veninga , C C M & Hak , E 2023 , ' Long-term comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events : A population-based retrospective inception cohort study in the Netherlands ' , BMJ Open , vol. 13 , no. 8 , e068721 . https://doi.org/10.1136/bmjopen-2022-068721;
2023
132
Cherney, David Z I, Dekkers, Claire C J, Barbour, Sean J, Cattran, Daniel, Abdul Gafor, Abdul Halim, Greasley, Peter J, Laverman, Gozewijn D, Lim, Soo Kun, Di Tanna, Gian Luca, Reich, Heather N, Vervloet, Marc G, Wong, Muh Geot, Gansevoort, Ron T, Heerspink, Hiddo J L
Veröffentlicht in: DIAMOND investigators , Cherney , D Z I , Dekkers , C C J , Barbour , S J , Cattran , D , Abdul Gafor , A H , Greasley , P J , Laverman , G D , Lim , S K , Di Tanna , G L , Reich , H N , Vervloet , M G , Wong , M G , Gansevoort , R T & Heerspink , H J L 2020 , ' Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND) : a randomised, double-blind, crossover trial ' , Lancet Diabetes & Endocrinology , vol. 8 , no. 7 , pp. 582-593 . https://doi.org/10.1016/S2213-8587(20)30162-5;
2020
Veröffentlicht in: DIAMOND investigators , Cherney , D Z I , Dekkers , C C J , Barbour , S J , Cattran , D , Abdul Gafor , A H , Greasley , P J , Laverman , G D , Lim , S K , Di Tanna , G L , Reich , H N , Vervloet , M G , Wong , M G , Gansevoort , R T & Heerspink , H J L 2020 , ' Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND) : a randomised, double-blind, crossover trial ' , Lancet Diabetes & Endocrinology , vol. 8 , no. 7 , pp. 582-593 . https://doi.org/10.1016/S2213-8587(20)30162-5;
2020
133
134
Macdonald, Thomas M, Hawkey, Chris J, Ford, Ian, McMurray, John J V, Scheiman, James M, Hallas, Jesper, Findlay, Evelyn, Grobbee, Diederick E, Hobbs, F D Richard, Ralston, Stuart H, Reid, David M, Walters, Matthew R, Webster, John, Ruschitzka, Frank, Ritchie, Lewis D, Perez-Gutthann, Susana, Connolly, Eugene, Greenlaw, Nicola, Wilson, Adam, Wei, Li, Mackenzie, Isla S
Veröffentlicht in: Macdonald , T M , Hawkey , C J , Ford , I , McMurray , J J V , Scheiman , J M , Hallas , J , Findlay , E , Grobbee , D E , Hobbs , F D R , Ralston , S H , Reid , D M , Walters , M R , Webster , J , Ruschitzka , F , Ritchie , L D , Perez-Gutthann , S , Connolly , E , Greenlaw , N , Wilson , A , Wei , L & Mackenzie , I S 2017 , ' Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib : the Standard care vs. Celecoxib Outcome Trial (SCOT) ' , European Heart Journal , vol. 38 , no. 23 , pp. 1843-1850 . https://doi.org/10.1093/eurheartj/ehw387;
2017
Veröffentlicht in: Macdonald , T M , Hawkey , C J , Ford , I , McMurray , J J V , Scheiman , J M , Hallas , J , Findlay , E , Grobbee , D E , Hobbs , F D R , Ralston , S H , Reid , D M , Walters , M R , Webster , J , Ruschitzka , F , Ritchie , L D , Perez-Gutthann , S , Connolly , E , Greenlaw , N , Wilson , A , Wei , L & Mackenzie , I S 2017 , ' Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib : the Standard care vs. Celecoxib Outcome Trial (SCOT) ' , European Heart Journal , vol. 38 , no. 23 , pp. 1843-1850 . https://doi.org/10.1093/eurheartj/ehw387;
2017
135
136
137
138
139
140